| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 746351 | Null | 0.0137891122538509 | 0.27728968 |
| NSC 747459 | Null | 0.0137891122538509 | 0.25889255 |
| NSC 753189 | 3,5-dichloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide | 0.0137891122538509 | 0.38058892 |
| NSC 753664 | Null | 0.0137891122538509 | 0.48106802 |
| NSC 756188 | GSK718429A | 0.0137891122538509 | 0.11954239 |
| NSC 756407 | GW853606X | 0.0137891122538509 | 0.14520129 |
| NSC 760476 | 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione | 0.0137891122538509 | 0.1948176 |
| NSC 7821 | [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride | 0.0137891122538509 | 0.033689686 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.013789112253851 | 0.46350388 |
| NSC 244404 | Null | 0.013789112253851 | 0.30659347 |